Background: Chronic kidney disease (CKD) has reached epidemic proportions worldwide and in the United States, racial minorities reach end stage renal disease (ESRD) at a disproportionate rate. A rural state in the heart of Appalachia, West Virginia leads the nation in rates of incident ESRD, despite its predominantly Caucasian population. Characteristics of this racially homogeneous CKD population are herein examined for their impact on progression to ESRD or death.
Introduction
Chronic kidney disease (CKD) is recognized as a major public health problem, and since 1994, West Virginia has led the United States in numbers of patients per million population starting dialysis because of end stage renal disease (ESRD) (Fig. 1) [1, 2] . In 2007, the incidence and prevalence of CKD among West Virginia Medicare patients was among the highest in the nation, along with 6 other states, 2 of which (Kentucky and Georgia) have counties in Appalachia [2] . In 2007, West Virginia's rate of dialysis starts (434.3 per million population) was 4th highest for incident diabetic ESRD and 10th highest for incident ESRD due to non-diabetic causes [2] . Only 2 other states (Texas at 418.0 and Louisiana at 400.4) had overall incident ESRD rates exceeding 400 per million population with Louisiana being higher in non-diabetic ESRD incidence than West Virginia (228.60 vs. 214.3), but lower for diabetic ESRD incidence (171.5 vs 214.0). Diabetic incident ESRD rates were higher in Texas, New Mexico and Hawaii though these states had less non-diabetic incident ESRD than West Virginia [2] . Challenges associated with CKD in West Virginia include the state's high prevalence of risk factors for CKD, namely, diabetes and hypertension, which are leading causes of kid-ney disease [3] . Perhaps most curious is the finding that West Virginia has high ESRD rates for both diabetic and non-diabetic patients. Non-diabetic CKD is difficult to quantify and additional factors posing heightened risk for ESRD in West Virginia have yet to be clarified. Further, projections that the ESRD population in the United States will reach 784,000 patients by the year 2020 underscore the need to address regional variations and secondary risk factors for CKD [4] . In this review, the characteristics of patients with CKD in the north central West Virginia region of Appalachia are described and factors associated with progression of CKD to the need for dialysis or death examined.
Materials and Methods
Demographic information, clinical characteristics and laboratory values were reviewed for 5,408 patients seen by our university nephrology group between January 1, 2000 and July 31, 2010. Patients were seen and evaluated at 1 of 9 facilities, including a main campus CKD clinic and 8 outreach sites ranging from 30 minutes to 2.5 hours. All participants were aged 18 or older and hailed from 1 of 45 West Virginia counties or lived in a county from Maryland or Pennsylvania in close proximity to 1 of the CKD clinics.
Blood and urine studies were done on a serial basis according to CKD stage. Patients underwent phlebotomy and provided urine for analysis at various rural sites in north central West Virginia; results were electronically captured or communicated by telefax for manual entry into a database for CKD patients registered in the clinics. Kidney function as estimated by glomerular filtration rate (eGFR) was calculated for 4,258 patients and 3,091 of these had serum albumin coinciding with their first visit. Results for hemoglobin, parathyroid hormone and calcium levels were available for 2025, 1692 and 2185 patients, respectively. Serial lab values were available for 3,749 patients. Patients were medically managed by 1 of our 5 physicians or 4 nurse practitioners; the majority seen initially by a physician with serial followup by a nurse practitioner.
Census statistics for annual median household income and the percent of residents living below the federal poverty level (% < FLP) ($10,827 and $18,346 for an individual and family of 3, respectively), were ranked for each county of West Virginia [5, 6] .
Informed consent for inclusion in the CKD registry was obtained after approval by the Institutional Review Board of West Virginia University.
Baseline characteristics of patients are described using mean values ± SD and proportions. Estimates of persons with CKD from the US general population were taken from publicly available data from the National Health and Nutrition Examination Survey (NHANES) 1999 -2006 [7] . Unpaired t tests were used to compare means and 2 × 2 contingency tables to compare categorical data. A P value of < 0.05 was considered statistically significant.
The significance of associations between individual risk factors and time-to-event (death or start of dialysis) was assessed using Cox Proportional Hazards models. Parameters assessed for risk were each patient's first blood test results for the following: albumin, hemoglobin, serum calcium and parathyroid hormone level. Three economic county-level variables were available for analysis: % < FPL, annual median household income and percent of high school graduates. A principal component analysis on correlations of the 3 variables showed that the first component captured nearly 83% of the variation in the set of all 3. The % < FPL loaded negatively on the component while the other 2 variables (annual median household income and percent high school graduates) loaded positively on it. We termed the collective representation of these 3 variables the economic index because higher values of the variable indicated counties of residence with more favorable economic values. Economic index served as an additional risk factor. 
Results
Demographic and clinical information for 4,258 patients seen between January 1, 2001 and July 31, 2010 were reviewed and are presented in Tables 1 and Table 2 .
Patients were predominantly Caucasian (94.3%) with a mean age of 60.1 ± 16.7 years. The prevalence of African Americans (3.24%) was significantly lower than that reported in national CKD prevalence estimates (7.3%); (P < 0.0001). Nearly half (1,872 or 44%) were older than 65 years of age at diagnosis with Stage 4 CKD having the largest proportion (60%) of patients older than 65 years. Women comprised 52 percent of the group overall and were similar in age to men (60.31 ± 16.78 vs. 59.83 ± 16.5; mean ± SD). Diabetes was present in 39% and the proportion of patients with diabetes increased with declining renal function and later stage.
Mean hemoglobin, parathyroid hormone and serum calcium levels at first presentation were 12.82 ±1.79 gm/dl, 128.33 ± 133.98 pg/dl and 9.11 ± 0.85 mg/dl respectively (mean ± SD) ( Table 2 ). Albumin levels declined with worsening kidney function (increasing stage), ranging from 3.71 ± 0.61 in patients with mild CKD (Stage 2) to 3.21 ± 0.36 in those with severely reduced kidney function (CKD Stage 5) . At all stages the mean albumin level was less than 3.8 gm/dl with 39% of patients overall and 33 -62% of patients with Stages 3 -5, respectively, presenting with albumin levels ≤ 3.5 gm/dl. Albumin levels for Stages 3 -5 for our patient group are compared with those of national estimates as shown in Table 3 and Figure 2 [8, 9] . Of the entire group, 3,734 (88%) hailed from 45 West Virginia counties, 38 of which have higher % < FPL than the national average, with 41 having annual median household incomes below the national average of $52,029. Median household income ($35,895) and % < FPL (17.6 %) for the CKD group was similar to the state overall ($37,528 and 17.4 Table 3 . Albumin Levels of West Virginia Patients vs. NHANES Dataset [9] and a Large Urban Public Health System [9] P < 0.0001 except where *P = 0.001; †P = 0.16; ‡ = NS. percent). The eGFR at presentation for patients from counties with high % < FPL was higher but not significantly so than that of patients from counties with low % < FPL; albumin levels at first presentation were significantly lower in the group from counties with high % < FPL than those patients from counties with low % < FPL (Table 4) . At all stages of eGFR, the majority (90%) came from counties where median household income was less than the national average. Four of West Virginia's 55 counties have life expectancy rates exceeding those of the national median; these counties were represented in our clinics by 783 patients [10, 11] . Presenting eGFR level of patients from these 4 counties (41.34 ± 1.00 ml/min) was significantly lower than that of those patients from counties with lower life expectancy rates (46.75 ± 0.59 ml/min); P < 0.0001. Presenting albumin also differed significantly, with patients from counties with the lowest life expectancy rates having the lowest albumins (3.71 ± 0.02 vs.3.48 ± 0.13) mean ± SE; P < 0.0001) ( Table 4) .
Clinical parameters for the 579 patients who died were similar to those of the overall group except the degree of hypoalbuminemia. Albumin levels of patients who died before starting dialysis were lower than those of patients who survived (3.25 ± 0.72 vs. 3.62 ± 0 .58; P < 0.0001). Proportional hazards models showed that patients from counties with higher values of the economic index variable had lower rates of progression to dialysis and better survival than those from poorer counties (P = 0.0162). In addition, patients presenting with higher albumin, higher calcium and higher hemoglobin levels had better survival and less progression to dialysis than those with lower albumin, calcium and hemoglobin levels, respectively (P < 0.0001) (Fig. 3 ). Patients presenting with higher parathyroid hormone levels had worse survival and faster progression to dialysis than those with lower values (P < 0.0001). Used in a multiple variable Cox Model, the resulting analysis showed significance for albumin (P = 0.0122), parathyroid hormone (P = 0.0001), hemoglobin (P = 0.0026) and a near significant result for calcium (P = 0.0931) (Fig. 2) . The directions of the effect of each variable remained the same as seen in the single variable models. In short, patients hailing from counties with low socioeconomic status had higher rates of progression to dialysis or death and hypoalbuminema, anemia, hyperparathyroidism and hypocalemia all independently correlated with reduced survival and more rapid progression to dialysis-dependence (P < 0.0001) (Fig. 2) .
Discussion
Projections that the ESRD population will exceed 784,000 patients by the year 2020 [4] underscore the need to address non-traditional and/or secondary risk factors for CKD, alone a public health problem of growing magnitude. In north central West Virginia, CKD patients are predominantly white, often hypoalbuminemic and diabetic; most resided in counties with low socioeconomic standing. Hypoalbuminemia was independently associated with increased rates of progression to dialysis or death as was anemia, hyperparathyroidism or hypocalemia. Patients hailing from counties with low socioeconomic status also had higher rates of progression to dialysis or death.
A predominantly rural state of 1.8 million people, West Virginia is the only state with all 55 of its counties in the confines of Appalachia. Appalachia, a term used to describe a cultural region in the eastern United States that stretches from the southern tier of New York state to northern Alabama, Mississippi, and Georgia, includes West Virginia, Pennsylvania, Ohio, Maryland, Kentucky, Virginia, North Carolina, Tennessee and South Carolina. The population in some areas of Appalachia such as West Virginia is aging, due in part to outmigration of young people and lower rates of immigrant migration to the region in the last half of the 20th century [12, 13] . Indeed, the highest age adjusted incidence rates of dialysis have occurred in the Mississippi Basin and through the Ohio Valley, an area encompassing most of Appalachia [12, 13] . Despite the increasingly older population in West Virginia, the proportion of patients older than 65 was less than half of the overall group and greater than half only in patients with Stage 4 CKD ( Table 1) . West Virginians, and in particular, West Virginia women, have shorter life expectancies than the national average with southern West Virginia having some of the lowest in the nation [10, 11] . Only 4 counties in West Virginia have life expectancies exceeding the national mean and life expectancies are reportedly on the decline in some West Virginia counties [10, 11] .
Historically, the Appalachian region has been medically under-served, and rates of poverty, obesity, tobacco use, and limited educational attainment exceed those of other states [12, 13] . Socioeconomically, the state ranks well below the nation with higher percentages of West Virginians living below the federal poverty level (% < FPL) (17.4% vs. 13.2%, respectively) and hailing from counties with lower median household incomes than national levels ($37,528 vs. $52,029, respectively) [5, 6] . West Virginia's physician population is clustered in the least rural areas, requiring patients to travel long distances for specialty physician care. Those without the social or economic means to travel often present for care well past the period when medical intervention could provide benefit. Thus, geographic distance from health care may be a contributing factor, though the high incident rate of non-diabetic ESRD among West Virginians remains largely unexplained. Studies associating CKD with poverty in the US largely invoke race as a contributing factor with African Americans and other ethnic minorities generally faring worse than whites, particularly when of lower affluence [14] [15] [16] [17] [18] [19] [20] [21] . As reflected in our CKD cohort, a high proportion of West Virginia's population is non-Hispanic white (93.5% vs 65.6% for US) with a low prevalence of African Americans (3.6% vs 12.8% for US) [5, 6] . West Virginia's racially homogeneous population and the CKD population described herein contrast greatly with other CKD studies where between 28 and 51% of individuals were found to be white [8, 9] . The paucity of African Americans in West Virginia and in our CKD patient population in particular precludes speculations related to racial disparities, however, suggests an impact of other factors on progression that is not limited to racial or ethnic minorities.
A link between poverty and malnutrition might be postulated by the high prevalence of hypoalbuminemic CKD patients living in socioecononomically disadvantaged counties. Indeed, rural households in the US are particularly vulnerable to food security and food insecurity [22, 23] has been associated with low quality diets in the Mississippi delta [24] . Anecdotal reports of the so-called Appalachian diet (high in carbohydrates, fat and prepared foods) are in keeping with surveys reporting comparatively low consumption of fruits and vegetables when compared to other states, as well as the high prevalence of obesity in West Virginia [3] . Diets high in saturated fats were highly prevalent in West Virginia children, 42 percent of whom were at the 85th percentile for body mass index [25] . Among NHANES participants, energy and nutrient intakes of adults from families considered food insufficient were found to be lower than those of their food sufficient counterparts [26] . Compared to those from food-sufficient families, adults from food-insufficient families had lower serum albumin levels and were more likely to have serum albumin < 3.5 g/dl [26] .
A consequence of altered albumin homeostasis, low serum albumin is a marker of malnutrition and chronic inflammation. Protein malnutrition is considered of minor importance as a contributor to the low albumin levels seen in ESRD, a stance supported by the lack of effectiveness of nutritional supplements in normalizing serum albumin. In ESRD, inflammation is thought to be primary, causing a decline in the rate of albumin synthesis with hypoalbuminemia being a manifestation, rather than a direct result of disease. Despite a move toward earlier recognition and initiation of dialysis mean serum albumin levels of incident dialysis patients declined significantly over time between 1996 and 2004 [27, 28] . Mean albumin levels of incident dialysis patients of 3.1 -3.2 g/dl reported within the last decade are in keeping with those among advanced CKD patients from a large integrated healthcare system, nearly 1/4 of whom had an albumin level below 3.5 g/dl as well as our late stage West Virginia patient, where this prevalence was 62% [8] . In our patients, a low serum albumin at first presentation was not uncommon and compared to the NHANES III population, members of a large health care system and a cohort of CKD patients considered urban poor, West Virginia CKD patients had significantly greater prevalence of hypoalbuminemia at every level of renal function [8, 9] .
While the relative contributions of chronic inflammation and malnutrition to low serum albumin are not well delineated in earlier stages of CKD, the high rate of hypoalbuminemia among incident dialysis patients suggests that such drivers of hypoalbuminemia are operative in earlier stages of CKD, long before patients reach dialysis-dependence. Others have reported an independent relationship between all-cause mortality and serum albumin level in patients with moderate to severely advanced CKD [29] . These observations suggest a predictive role for a low serum albumin and further suggest that the potential role of a deficient nutritional intake, in addition to that of chronic inflammation, is worthy of further study. The complexities are reflected in a recent model developed and validated for estimating progression of CKD, which utilizes albumin and a number of other clinical and biochemical parameters [30] .
In reviewing and analyzing our data, the following limitations are recognized. First, because of logistic difficulties associated with retrieval of blood and urine lab results, not all lab data was included for every patient nor were urine studies or weights available. Lab data for patients whose blood was drawn locally at a non-university-affiliated lab was communicated by telefax to our office where it was manually entered into our electronic medical record and thus amalgamated with any lab work done on site. Second, transplanted patients who did not reach either end point of death or dialysis are included as CKD patients by their stage of CKD. Third, socioeconomic data is by county level only and not based on individual patient account. Thus, our analyses are based on county of residence for a given patient and not a patient's individual socioeconomic status. Fourth, as noted above, because socioeconomic status is not known on a patient level, no direct correlations between socioeconomic and clinical factors can be made. Fifth, the racial homogeneity of our predominantly Caucasian patient population precludes conclusions involving the impact of other racial or ethnic groups. Sixth, markers of chronic inflammation were not measured, thus their contribution to the hypoalbuminemic state in these patients limits our conclusions as to the etiology of hypoalbuminemia in our patients.
Pathogenetic factors related to progressive disease notwithstanding, we suggest that poverty and culture are key factors in the development of risk and progression of CKD and may trump race as a risk factor. The high prevalence of CKD, coupled with the high incidence of ESRD in this predominantly Caucasian state underscore the need to focus on poverty, irrespective of race or ethnicity.
